Overseas Inspection: There are Defects CFDA Chasing

Weekly CFDA News Roundup (July 16th to July 22nd)
July 25, 2018
CFDA New Medical Device Classification Catalogue Effective August 1st, 2018
August 1, 2018

Overseas Inspection: There are Defects CFDA Chasing

Following the 13th Five Year Plan (2016-2020), CFDA has conducted overseas inspection covering all imported high-risk medical devices. Since November 2017 when CFDA began to publish overseas inspection results, 24 foreign manufacturers have been found with issues. Inspected facilities are located in US, UK, Germany, Japan, South Korea, Switzerland, France and Australia

 

For the draft guideline on Medical Device Overseas Inspection, click HERE

For the webinar on overseas inspection, click HERE

 

Observations were categorized by active and non-active medical devices and IVD:

 7 active device manufacturers got caught with 40 observations. Agfa HealthCare (Germany) and St. Jude Medical (US) and Terumo (Japan) were included.


 

12 non-active device manufacturers got caught with 58 observations. Covidien (US) and Zimmer (Switzerland) were included; Biocomposites (UK) was suspended for importing.

5 IVD manufacturers got caught with 16 observations. Beckman Coulter (US) and DiaMed GmbH (Switzerland) were included; Leica Biosystems (UK) was suspended for importing. 

 

Keep yourself updated with CFDA News Roundup, click HERE to opt-in. For market access newsletter, click HERE. For CRO services in China, click HERE

 

About China Med Device, LLC 

China Med Device, LLC (https://ChinaMedDevice.com) provides turn-key solutions for western medical device/IVD companies to enter China with regulation and commercialization services. Our CFDA regulatory services cover strategy, premarket submission, clinical evaluation, CRO, QA and post market compliance. We are experienced in handling innovation approvals and priority reviews. Our commercial services cover market assessment research, reimbursement, partnership, distribution qualification and management. We have offices in Beijing, Suzhou and Boston. Our management team has 100+ years of combined experience in medical device and IVD and has been involved with 1,000+ CFDA certificates and 250+ companies’ success.